View in EDS HTML Full Text PDF Full Text

A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China.

Saved in:
Bibliographic Details
Title: A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China.
Authors: Wang, Ying1 (AUTHOR), Wu, Depei1 (AUTHOR) wudepei@suda.edu.cn, Zhang, Xiang1 (AUTHOR), Li, Yuhua2 (AUTHOR), He, Yanjie2 (AUTHOR), Liu, Qifa3 (AUTHOR), Xuan, Li3 (AUTHOR), Li, Zhenyu4 (AUTHOR), Qi, Kunming4 (AUTHOR), Sun, Yuqian5 (AUTHOR), Wang, Shunqing6 (AUTHOR), Mo, Wenjian6 (AUTHOR), Gao, Lei7 (AUTHOR), Hua, Ye8 (AUTHOR), Wang, Yu8 (AUTHOR), Zhang, Ying8 (AUTHOR)
Source: BMC Medicine. 3/26/2024, Vol. 22 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17417015
DOI:10.1186/s12916-024-03348-5